Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (141-150 of 1,622) with videos related to

Pageof 163
Sort By:
Seminars in Oncology|August 22, 2000
Weekly paclitaxel in the management of ovarian cancerM Markman
Cleveland Clinic Journal of Medicine|April 26, 2000
The genetics, screening, and treatment of epithelial ovarian cancer: an updateM Markman
Critical Reviews in Oncology/Hematology|May 23, 2001
Intraperitoneal chemotherapy is appropriate first line therapy for patients with optimally debulked ovarian cancerM Markman
Gynecologic Oncology|December 6, 2001
Why study third-, fourth-, fifth-, ...line chemotherapy of ovarian cancer?M Markman
Cancer Investigation|April 9, 2001
Monitoring and improving quality of cancer care: easy to recommend, difficult to accomplishM Markman
Current Oncology Reports|December 21, 2000
Cancer, psychologic factors, and behavior: a complex and controversial relationshipM Markman
Gynecologic Oncology|May 17, 2011
Can weekly topotecan substitute for a multi-day regimen in the treatment of ovarian cancer? Sadly, 10 years later the answer remains unknownMaurie Markman
Current Oncology Reports|January 12, 2011
Commentary: Implications of cancer managed as a "chronic illness"Maurie Markman
Journal of the National Comprehensive Cancer Network : JNCCN|January 15, 2011
Counterpoint: chemosensitivity assays for recurrent ovarian cancerMaurie Markman
Journal of Oncology Practice|September 23, 2010
Standard of care versus standards of care in oncology: a not so subtle distinctionMaurie Markman
Pageof 163

Showing results (141-150 of 1,622) with videos related to

Sort By:
Pageof 163
Seminars in Oncology|August 22, 2000
Weekly paclitaxel in the management of ovarian cancerM Markman
Cleveland Clinic Journal of Medicine|April 26, 2000
The genetics, screening, and treatment of epithelial ovarian cancer: an updateM Markman
Critical Reviews in Oncology/Hematology|May 23, 2001
Intraperitoneal chemotherapy is appropriate first line therapy for patients with optimally debulked ovarian cancerM Markman
Gynecologic Oncology|December 6, 2001
Why study third-, fourth-, fifth-, ...line chemotherapy of ovarian cancer?M Markman
Cancer Investigation|April 9, 2001
Monitoring and improving quality of cancer care: easy to recommend, difficult to accomplishM Markman
Current Oncology Reports|December 21, 2000
Cancer, psychologic factors, and behavior: a complex and controversial relationshipM Markman
Gynecologic Oncology|May 17, 2011
Can weekly topotecan substitute for a multi-day regimen in the treatment of ovarian cancer? Sadly, 10 years later the answer remains unknownMaurie Markman
Current Oncology Reports|January 12, 2011
Commentary: Implications of cancer managed as a "chronic illness"Maurie Markman
Journal of the National Comprehensive Cancer Network : JNCCN|January 15, 2011
Counterpoint: chemosensitivity assays for recurrent ovarian cancerMaurie Markman
Journal of Oncology Practice|September 23, 2010
Standard of care versus standards of care in oncology: a not so subtle distinctionMaurie Markman
Pageof 163